CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
University of Washington
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
Yale University
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Genmab
University of Washington
Alliance for Clinical Trials in Oncology
Masonic Cancer Center, University of Minnesota
Hackensack Meridian Health
Milton S. Hershey Medical Center
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
Fred Hutchinson Cancer Center
Incyte Corporation
University of Miami
Gilead Sciences
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Baptist Health South Florida
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Henry Ford Health System
Children's Oncology Group
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Center for International Blood and Marrow Transplant Research
Thomas Jefferson University
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Ruijin Hospital
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Thomas Jefferson University
University of Nebraska